Certified by Founder
Lodge
Persist AI
start up
United States
- Woodland, California
- 07/08/2023
- Seed
- $4,000,000
Developing extended-release PLG drug formulations takes $10M+ and 5-10 years. We enable drug manufacturers and CROs to shorten formulation discovery time by 30-50% by utilizing our automation and machine learning platform.
- Industry Biotechnology
- Website https://www.persist-ai.com/
- LinkedIn https://www.linkedin.com/company/persist-ai/about/
Related People
Karthik RamanCo Founder
United States -
Woodland, California
**Follow me for practical ways to save time during R&D and Manufacturing of Drug Products**
At Persist, we you reduce PLGA-based formulation development time by 50% and get you to market faster by:
- Discovering viable formulations, building them, and testing within weeks instead of years
- Predicting shelf-stability of both the drug and formulation
- Seamlessly scaling promising formulations from mg to kg quantities
Syntracts | $5,300,000 | (Oct 24, 2025)
GradBridge | $20,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
CipherOwl | $15,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
Vermeer | $10,000,000 | (Oct 24, 2025)
GammaTime | $14,000,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Apriority Financial, Inc. | $2,300,000 | (Oct 24, 2025)
OneAM | $4,700,000 | (Oct 24, 2025)
🌱 Rightcharge | $2,131,920 | (Oct 24, 2025)
Tensormesh | $4,500,000 | (Oct 24, 2025)